Sartorius Stedim Biotech (Sartorius Stedim Biotech) Accounts Payable & Accrued Expense : $488 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Accounts Payable & Accrued Expense?

Sartorius Stedim Biotech's quarterly accounts payable & accrued expense declined from Jun. 2023 ($695 Mil) to Sep. 2023 ($611 Mil) and declined from Sep. 2023 ($611 Mil) to Dec. 2023 ($488 Mil).

Sartorius Stedim Biotech's annual accounts payable & accrued expense increased from Dec. 2021 ($470 Mil) to Dec. 2022 ($489 Mil) but then declined from Dec. 2022 ($489 Mil) to Dec. 2023 ($488 Mil).

Sartorius Stedim Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sartorius Stedim Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Accounts Payable & Accrued Expense Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

184.83

299.58

470.40

488.67

488.44

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															488.67	717.56	694.80	610.57	488.44

Sartorius Stedim Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.